Transcranial Sonographic Evaluation of Preterm Neonates Presenting With Seizures and Its Association With IA
NCT ID: NCT07051382
Last Updated: 2025-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
122 participants
OBSERVATIONAL
2025-03-17
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Ultrasound Screening of Nursery Unit Neonatesfor Brain Abnormalities
NCT05113108
Study of Bedside EEG to Evaluate Brain Injury in Premature Newborns
NCT00516334
Transcranial Ultrasound and Transcranial Doppler in Diagnosis and Detection of Outcome in Infants With Neurological Diseases
NCT06352931
The Effect of AI-assisted cEEG Diagnosis on the Administration of Antiseizure Medication in Neonatal Seizures
NCT05036395
Fetal Brain Growth - Pilot Study
NCT05994443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Sonographic Examination (Cranial Ultrasound)
No evidence of intracranial abnormalities such as intraventricular hemorrhage, germinal matrix hemorrhage, periventricular leukomalacia, hydrocephalus, or infarction.
Brain structures were assessed to be age-appropriate for gestational development.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Seizures having any birth weight and gestational age.3.6.2
Exclusion Criteria
* Extra-cranial anomalies causing seizures such as arteriovenous malformation (AVM) or metabolic diseases.
1 Week
20 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Superior University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Naveed Babur
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohmand medical complex hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MSAHSW/Batch-Fall23/921
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.